CYP17A1

protein-coding

cytochrome P450 family 17 subfamily A member 1, the group of Cytochrome P450 family 17

Gene summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]

Previous symbols:
  • CYP17

MANE transcript

NM_000102.4

Inheritance

AR

ClinVar variants

P:154U:102B:211

Top phenotype

Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency

gnomAD constraint

pLI —, LoF o/e 0.47

Max pathogenic AF

—

Genomic locus

chr10:102,830,531-102,837,472

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~6.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

46,XY disorder of sex development due to isolated 17,20-lyase deficiencySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0019597

Submitter: Orphanet

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008730

Submitter: Orphanet

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008730

Submitter: Natera

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008730

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiencyAR

Manifestation: Endocrine;Genitourinary; Oncologic

Intervention: Endocrine; Genitourinary; Oncologic

Rationale: Individuals may not necessarily manifest with adrenal crisis, but mineralocorticoid excess may result in severe hypokalaemic hypertension, and awareness may allow preventive measures and treatment (eg, including glucocorticoids and mineralcorticoid antagonists); Treatment of genitourinary anomalies, as well as related hypogonadotrophic hypogonadism (eg, with hormone replacement therapy, as well as surgery in some individuals), can be beneficial; Due to risk of malignancy, gonadectomy may be indicated in genotypic males

Refs: 4288776; 6039879; 4303304; 5456802; 999330; 6976525; 2843762; 2026124; 1648117; 2808364; 7629254; 8855840; 9360545; 9326943; 9177409; 11549685; 14671162; 16121340; 18559916; 20170344; 21823532; 22452398; 21550081; 22954317Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CYP17A1 variants in ClinVar

14 Conditions Cataloged
not providedTotal: 443
Deficiency of steroid 17-alpha-monooxygenaseTotal: 173
Inborn genetic diseasesTotal: 39
Congenital adrenal hyperplasiaTotal: 21
CYP17A1-related disorderTotal: 19
17-alpha-hydroxylase/17,20-lyase deficiency, combined completeTotal: 19
not specifiedTotal: 16
17-alpha-hydroxylase/17,20-lyase deficiency, combined partialTotal: 10

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000102.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
6
clinvar
201
clinvar
209
missense
23
clinvar
37
clinvar
92
clinvar
10
clinvar
162
nonsense
20
clinvar
8
clinvar
1
clinvar
29
start loss
3
clinvar
3
frameshift
25
clinvar
20
clinvar
45
splice donor/acceptor (+/-2bp)
9
clinvar
7
clinvar
3
clinvar
19
Total78761022110467

Highest pathogenic variant AF is 0.00007289792

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 54 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000102.4RefSeqNP_000093.18MANE Select
ENST00000369887.4EnsemblENSP00000358903.38MANE Select
ENST00000638190.1EnsemblENSP00000492539.16Standard
ENST00000638190.2EnsemblENSP00000492539.16Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Cortisol synthesis and secretion - Homo sapiens (human)
  • Cushing,s syndrome - Homo sapiens (human)
  • Steroid hormone biosynthesis - Homo sapiens (human)
  • Prolactin signaling pathway - Homo sapiens (human)
  • Ovarian steroidogenesis - Homo sapiens (human)

Biological Process

  • steroid biosynthetic process
  • androgen biosynthetic process
  • glucocorticoid biosynthetic process
  • sex differentiation
  • steroid metabolic process

Molecular Function

  • steroid 17-alpha-monooxygenase activity
  • iron ion binding
  • oxygen binding
  • heme binding
  • 17-alpha-hydroxyprogesterone aldolase activity

Cellular Component

  • endoplasmic reticulum
  • endoplasmic reticulum membrane
  • axon
  • neuronal cell body

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000369887
Coding exons
8
Length
7003
Individuals with no LoFs
125709
Homozygous LoFs
0
Heterozygous LoFs
39
Defined
125748
p
0.000155
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.242192770.7910.00001623337
Missense (PolyPhen)80107.320.745451292
Synonymous-0.01091141141.000.000007011002
Loss of Function2.16919.20.4689.92e-7226

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000120.00012rare
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish0.000110.000099rare
East Asian0.000540.00054rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.000140.00014rare
South Asian0.000230.00023rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Conversion of pregnenolone and progesterone to their 17- alpha-hydroxylated products and subsequently to dehydroepiandrosterone (DHEA) and androstenedione. Catalyzes both the 17-alpha-hydroxylation and the 17,20-lyase reaction. Involved in sexual development during fetal life and at puberty. {ECO:0000269|PubMed:22266943}.;
Disease
DISEASE: Adrenal hyperplasia 5 (AH5) [MIM:202110]: A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late- onset (NC or LOAH) and 'cryptic' (asymptomatic). {ECO:0000269|PubMed:10720067, ECO:0000269|PubMed:11549685, ECO:0000269|PubMed:11836339, ECO:0000269|PubMed:12466376, ECO:0000269|PubMed:14671162, ECO:0000269|PubMed:1515452, ECO:0000269|PubMed:1714904, ECO:0000269|PubMed:1740503, ECO:0000269|PubMed:19793597, ECO:0000269|PubMed:24140098, ECO:0000269|PubMed:24498484, ECO:0000269|PubMed:25650406, ECO:0000269|PubMed:2808364, ECO:0000269|PubMed:8027220, ECO:0000269|PubMed:8245018, ECO:0000269|PubMed:8345056, ECO:0000269|PubMed:8396144, ECO:0000269|PubMed:8550762, ECO:0000269|Ref.20}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.806

Intolerance Scores

LoFtool
0.455
RVIS EVS
-0.69
RVIS percentile EVS
14.97

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.897

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.